Haemophilia
Haemophilia is a group of hereditary clotting factor deficiency haemorrhagic disease. Including haemophilia a and haemophilia B, genetic FX1 deficiency. With positive family history of this disease, childhood disease, or mild traumatic or spontaneous bleeding after surgery more than, edema formation and bone bleeding, deformities characterized. Doctors currently no cure. Bleeding after blood transfusion dependence and additional blood clotting factor, not only medical expenses expensive and often produce antibodies for the blood results are poor, it can easily combined blood transfusion after AIDS, hepatitis and other complications. On the economics of drug speaking, 1st bleeding blood of the hospitalization mixture 1000~2000 billion, and lose factor VIII (365 ¥/one) 1~2 million more in funding to five times more funding reduction. On life, medical expenses are generally haemophiliacs 20 million, and by taking blood Friends mixture longest course one year, only 10,000 ~2 million life savings is nearly 200,000 yuan medical expenses, medical expenses reduced by more than 20 times, is the most typical example of the economics of the drug.
General use one week to stop bleeding may, weight, two weeks can VIII : C, ¢ù : C, ¢û : C increased use longer the three latter factors reactive rise higher, its efficacy and use of time is a correlation (see figure below).
I study Chinese medicine hospital blood of a mixture of blood, pain, swelling, prevention and treatment bone deformities and restore VIII : C, ¢ù : C, ¢û : C reactive role, with the restoration of clotting factor reactive to the drug. Have a highly-efficient, low-cost, the benefit of mankind, raising national quality role (Liu Shaanxi Translation. Rational use of blood agents. Xian : Shaanxi Science and Technology Press, 1987).
Disease cases were reported
(1)
Injury, male, 22 years old, Shen Yang Xian Shaanxi Hill Township Lo Tanzanian villagers home mound. At the age of seven patients for pulling bleeding two days. At the age of 15 eat careless bites tongue, bleeding five days. 21, for walking inadvertently, a right leg edema, pain, walk inconvenience. Upon inspection : the reactive low blood factor VIII (VIII : C 9.3%), ¢ù : C (64%) and ¢û : C (81%) normal, the diagnosis neurohypophyseal. After taking Professor Liu Shaanxi mixture of Chinese medicine study 100 blood paid, blood factor rose (see table below). Follow-up of 2 years, no bleeding and no abnormal joints, the current physical normal business in crash. Contact Tel : 029-84983765 (Please note time and time associated conversation manner)
Conclusions : Blood Friends mixture treatment haemophilia, not only can stop bleeding, swelling and prevent bone deformities, and can haemophilia VIII, ¢ù, ¢û latter factors reactive with haemophilia clotting factor may resume the types of reactive, and have stop bleeding, swelling and the prevention and treatment of bone deformities.
Chinese medicine treatment of haemophilia mixture of the blood of efficacy observed
Treatment time |
VIII : C (%) |
¢ù : C (%) |
¢û : C (%) |
Before treatment |
9.3 |
64 |
81 |
100 days of treatment |
14 |
80 |
96 |
£¨2£© Humou, male, 6 years old, Shaanxi Province county rocket villagers. For walking inadvertently injure themselves, left knee joint swelling, pain repeated attacks four years and eight, not to walk Zugen, of the reactive agent factor VIII medium low (VIII : C 3%), ¢ù : C (58%) and ¢û : C (94%) normal. Professor Liu Shaanxi taking blood for the study of Chinese medicine mixture one week edema disappeared, two weeks could get out of bed and walk activities, review VIII : C, ¢ù : C, ¢û : C reactive rise. Take 90-, three latter factor has markedly (see table below).
Contact Tel : 13572045989 his father died 13519133425 (Please note time and time associated conversation manner)
Conclusion : another certification, is a mixture of blood clotting factor VIII restore haemophilia : C ¢ù : C, ¢û : C drug, and with blood, swelling, prevention and treatment of bone deformities.
Chinese medicine treatment of haemophilia mixture of the blood of efficacy observed
Treatment time |
VIII : C (%) |
¢ù : C (%) |
¢û : C (%) |
Before treatment |
3.0 |
58 |
94 |
12 days of treatment |
4.0 |
61 |
96 |
60 days of treatment |
4.9 |
70 |
103 |
90 days of treatment |
9.0 |
82 |
109 |
|